Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YO Proteins is a Swedish private company that develops, manufactures, markets, and sells biotechnical and biomedical products, with a primary commercial focus on research reagents. Its catalog includes antibodies, collagens, fibronectin, integrins, urokinase-related reagents, immunoglobulins, and bioink products for laboratory and 3D cell-culture applications. The company states that it has operated since 2008 from the Karolinska Institutet Science Park area in Sweden and also describes internal biotech research activity in fibrotic diseases. Publicly accessible information indicates YO Proteins is a very small active company rather than a clinical-stage therapeutic developer. Based on available evidence, it is best characterized as a life science tools and specialty bioreagents supplier with limited disclosed therapeutic pipeline details.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YO Proteins.